1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-N0427
    Phellodendrine

    黄柏碱

    Inhibitor 99.60%
    Phellodendrine 是一种异喹啉生物碱,是黄柏皮层中的重要特征成分之一。Phellodendrine 通过调节 AKT/NF-κB 途径抵抗 AAPH 诱导的氧化应激。Phellodendrine 具有良好的抗氧化,抗炎作用。
    Phellodendrine
  • HY-N7980
    Rubipodanone A Activator 99.40%
    Rubipodanone A 是一种萘氢醌二聚体,对 A549、BEL-7402、HeLa、HepG2、SGC-7901 和 U251 细胞具有细胞毒性。Rubipodanone A 在 20 μM 和 40 μM 对 NF-κB 也显示出明显的激活作用。
    Rubipodanone A
  • HY-P10030
    DPLG3 Inhibitor 99.18%
    DPLG3 DPLG3是一种特异性免疫蛋白酶体 β5i 亚基抑制剂,IC50 为 4.5 nM。DPLG3 抑制小鼠 i-20S, IC50值为 9.4 nM。DPLG3 下调 NF-κB p50p65 的蛋白水平。DPLG3 可用于免疫疾病的研究。
    DPLG3
  • HY-N2590
    Lupenone 99.74%
    Lupenone 是一种具有口服活性的可从 Musa basjoo 中分离出的 lupine 型三萜类化合物。Lupenone Lupenone 可通过 PI3K/Akt/mTORNF-κB 信号通路发挥作用。Lupenone 具有抗炎、抗病毒、抗糖尿病和抗癌活性。
    Lupenone
  • HY-15027S1
    5-Aminosalicylic acid-d3

    美沙拉嗪 d3; 5-氨基水杨酸 d3

    99.38%
    5-Aminosalicylic acid-d3 是 5-Aminosalicylic Acid 的氘代物。 5-Aminosalicylic acid (Mesalamine) 是一种特异性的 PPARγ 激动剂,还抑制 p21-激活激酶1 (PAK1) 和 NF-κB
    5-Aminosalicylic acid-d<sub>3</sub>
  • HY-12383
    Pelubiprofen Inhibitor 99.27%
    Pelubiprofen 是一种具有口服活性的抗炎剂,可抑制 COX 酶活性 (对 COX-1COX-2IC50 为 10.66 和 2.88 μM)。Pelubiprofen 具有抗炎和镇痛作用。
    Pelubiprofen
  • HY-169053
    SU1261 Inhibitor
    SU1261 是一种 IKK 抑制剂,对 IKKα 和 IKKβ 的 Ki 值分别为 10 nM 和 680 nM。SU1261 可以抑制 U2OS 骨肉瘤细胞中非经典 NF-κB 信号传导。
    SU1261
  • HY-P1860A
    TNF-α (31-45), human TFA Activator
    TNF-α (31-45), human TFA 是一种有效的 NF-kB 通路激活剂,也是一种促炎细胞因子,可诱导坏死或凋亡。TNF α 通过 TNFR2 刺激 NF-κB 通路,促进癌症生长、侵袭和转移。
    TNF-α (31-45), human TFA
  • HY-W014223
    2,4′-Dihydroxybenzophenone

    二苯甲酮 -1

    Inhibitor 98.00%
    2,4′-Dihydroxybenzophenone (Ultraviolet absorber UV-0) 占据 MD2 的疏水口袋并阻止 TLR4 的二聚化。2,4′-Dihydroxybenzophenone 抑制 LPS 诱导的 mtROS 产生,并通过下调促炎介质、降低 MyD88 的表达、IRAK4 和 NF-κB 的磷酸化来抑制 LPS 诱导的炎症反应。2,4′-Dihydroxybenzophenone 也是一种紫外线吸收剂。
    2,4′-Dihydroxybenzophenone
  • HY-107665
    Ro 106-9920 Inhibitor ≥99.0%
    Ro 106-9920 是一种有效的 NF-kappaB 抑制剂。Ro 106-9920 具有研究肿瘤和癌症疾病的潜力。
    Ro 106-9920
  • HY-111954
    (+)-Erinacin A 99.97%
    (+)-Erinacin A (Erinacine A) 是一种可从猴头菌中分离出的氰烷二萜,具有抗癌,抗炎和神经保护活性。(+)-Erinacin A 能够通过激活了外源性和内源性凋亡 (apoptosis) 途径引发癌细胞死亡。(+)-Erinacin A 也能抑制 NO 合成酶 (iNOS) 的表达和硝基酪氨酸的产生来发挥炎症和神经保护作用,从而减少缺血性脑损伤。
    (+)-Erinacin A
  • HY-N3796
    Echinulin Activator 98.63%
    Echinulin (Echinuline) 是一种带有三苯甲基化吲哚部分的环状二肽。 Echinulin 有助于激活 T 细胞亚群,从而导致 NF-κB 活化。Echinulin 通过 NF-κB 途径发挥其免疫作用。Echinulin 具有作为免疫抑制剂的潜力。
    Echinulin
  • HY-N2101
    Benzoyloxypaeoniflorin

    苯甲酰氧化芍药苷

    Inhibitor 98.65%
    Benzoyloxypaeoniflorin 分离于 Paeonia suffruticosa 的根,是 tyrosinase 抑制剂,对蘑菇 tyrosinase 的 IC50为 0.453 mM。Benzoyloxypaeoniflorin 是 NF-κB 抑制剂,Benzoyloxypaeoniflorin 通过对血小板聚集和凝血的抑制作用,有助于改善血液循环。
    Benzoyloxypaeoniflorin
  • HY-N2106
    Dehydroevodiamine

    去氢吴茱萸碱

    99.93%
    Dehydroevodiamine 是从吴茱萸 Evodiae Fructus 中分离出的喹唑啉生物碱,对豚鼠心室肌细胞具有抗心律失常作用。Dehydroevodiamine 抑制 LPS 诱导的小鼠巨噬细胞中 iNOSCOX-2PGE2NF-κB 的表达。
    Dehydroevodiamine
  • HY-W005130
    2,4,6-Trihydroxybenzaldehyde

    2,4,6-三羟基苯甲醛

    Inhibitor 99.93%
    2,4,6-Trihydroxybenzaldehyde 是一种具有口服活性的 NF-ĸB 抑制剂。2,4,6-Trihydroxybenzaldehyde 具有抗肿瘤活性、抗癌细胞增殖活性和抗肥胖活性。
    2,4,6-Trihydroxybenzaldehyde
  • HY-13010S
    Laquinimod-d5 Inhibitor 98.25%
    Laquinimod-d5 (ABR-215062-d5) 是 Laquinimod 氚代物。Laquinimod (ABR-215062) 是一种可口服的羧酰胺衍生物,是一种有效的免疫调节剂,可防止中枢神经系统的神经变性和炎症。Laquinimod 减少星形胶质细胞 NF-κB 的活化以防止铜酮 (Cuprizone) 诱导的脱髓鞘。Laquinimod 具有用于多发性硬化症 (MS;RRMS 或 CPMS) 的复发缓解 (RR) 和慢性进行性 (CP) 形式以及神经退行性疾病研究的潜力。
    Laquinimod-d<sub>5</sub>
  • HY-19918A
    Anatabine dicitrate

    柠檬酸新烟草碱

    Inhibitor 99.03%
    Anatabine dicitrate 是一种烟草生物碱,可以穿过血脑屏障。Anatabine dicitrate 是一种有效的 α4β2 nAChR 激动剂。Anatabine dicitrate 通过阻止淀粉样蛋白前体蛋白的 β 裂解,抑制 NF-κB 激活,并降低淀粉样 β () 的产生。Anatabine dicitrate 具有抗炎作用,可用于神经退行性疾病的研究。
    Anatabine dicitrate
  • HY-B0190
    Nafamostat

    萘莫司他

    Nafamostat,一种抗凝剂,是一种人工合成的丝氨酸蛋白酶 (serine protease) 抑制剂。Nafamostat 具有抗癌和抗病毒作用,Nafamostat 通过上调肿瘤坏死因子受体 1 (TNFR1) 的表达诱导凋亡 (apoptosis),可用于动脉壁病理性增厚的发生发展。
    Nafamostat
  • HY-N0208
    Kaempferol-3-O-glucorhamnoside

    百蕊草素I; 山柰酚-3-O-葡萄糖鼠李糖苷;

    Inhibitor 99.39%
    Kaempferol-3-O-glucorhamnoside 是一种来源于植物 Thesium chinense Turcz 的类黄酮,在体外和体内均能通过 MAPK 和 NF-κB 通路抑制炎症反应。
    Kaempferol-3-O-glucorhamnoside
  • HY-N0592
    Demethyleneberberine

    去亚甲基小檗碱

    Inhibitor ≥98.0%
    Demethyleneberberine 是一种天然线粒体靶向抗氧化剂。Demethyleneberberine 通过抑制 NF-κB 通路和调节 Th 细胞的平衡来减轻小鼠结肠炎并抑制炎症反应。Demethyleneberberine 可作为 AMPK 激活剂,用于非酒精性脂肪性肝病 (NAFLD) 的研究。
    Demethyleneberberine
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.